Search company, investor...


About M2i

M2i produces radiopharmaceuticals for use in Positron Emission Tomography imaging. Its aim is to supply a range of licensed products to PET imaging centers across all geographical regions of Ireland.

Headquarters Location

Blackrock Clinic Blackrock



+353 12064266

Missing: M2i's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: M2i's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest M2i News

Essential partner for smart factories

Mar 10, 2023

Essential partner for smart factories Share By Kyeongkeun Kang M2I Corp is a specialized smart factory solutions provider. Key investment points include: 1) localization of its HMI solution; 2) customer diversification; 3) sales growth for its smart SCADA solution; and 4) strong valuation merit compared to its peers. Serves as gateway to connect production equipment with main systems Standing as a specialized smart factory solutions provider, M2I Corporation boasts such core products as its smart human-machine interface (HMI) and smart supervisory control and data acquisition (SCADA) solutions, which serve as gateways to connect production equipment with main systems (MES/ERP). M2I Corp’s solutions are essential for the construction of smart factories. Based on its strengths in general-purpose use and customization, the firm has established itself as a number-one play in the semiconductor and display-related smart factory solutions market. In addition, its rich track record has allowed the company to secure clients from a diverse range of industries (eg, rechargeable battery and pharmaceutical/bio). Offers earnings growth, valuation appeal, and robust financials Backed by the localization of HMI products, effects of client diversification, and strong prospects for the full-fledged generation of smart SCADA/solution sales (2022E W1.6bn → 2023F W7.3bn), M2I Corp should enjoy accelerated earnings growth from this year. For 2023, we forecast sales of W59.5bn (+43.2% y-y) and OP of W19bn (+67.0% y-y; OPM of 31.9%). M2I Corp’s shares are trading at a 2023F P/E of 10.4x, a level much lower than the average P/E of 31.6x for its smart factory-related peer group. Considering its robust financial structure (debt ratio of 12% and 2022E net cash of W26.9bn), strong growth potential (2023F OP growth of 67% y-y), and solid profitability (2023F OPM of 31.9%), we view the firm’s shares as being excessively undervalued compared to those of peers. POPULAR

M2i Frequently Asked Questions (FAQ)

  • Where is M2i's headquarters?

    M2i's headquarters is located at Blackrock Clinic, Dublin.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.